| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Myriad Genetics, Inc. (MYGN) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 25 sells. MYGN is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.07M | $4.81M | - | |
| Other | 573.4K | $2.58M | - | |
| COO | 381.8K | $1.72M | - | |
| Other | 251.9K | $1.13M | - | |
| Other | 170.2K | $765.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 4, 2021 | Lanchbury Jerry S81 | Chief Scientific Officer | Sale+OE | 100,000 | $34.68 | $3,467,763.91 | -6.7% | -11.5% | -21.3% | |
| Aug 3, 2021 | Riggsbee Richard Bryan51 | Chief Financial Officer | Sell | 14,983 | $35.14 | $526,475.65 | -4.4% | -11.5% | -26.4% | |
| Aug 3, 2021 | Langer Dennis63 | Director | Sale+OE | 30,000 | $34.75 | $1,042,500.00 | -25.1% | -11.5% | -26.4% | |
| Jul 13, 2021 | Lanchbury Jerry S81 | Chief Scientific Officer | Sale+OE | 93,295 | $33.64 | $3,138,273.41 | -9.1% | -5.2% | -36.7% | |
| Jul 9, 2021 | Lanchbury Jerry S81 | Chief Scientific Officer | Sale+OE | 50,000 | $32.62 | $1,631,037.06 | -6.7% | -4.4% | -40.7% | |
| Jul 7, 2021 | Lanchbury Jerry S81 | Chief Scientific Officer | Sale+OE | 32,308 | $32.27 | $1,042,660.12 | -6.5% | -1.6% | -38.8% | |
| Jun 28, 2021 | Lanchbury Jerry S81 | Chief Scientific Officer | Sale+OE | 6,812 | $32.39 | $220,608.32 | -1.0% | +4.1% | -41.1% | |
| Jun 25, 2021 | Lanchbury Jerry S81 | Chief Scientific Officer | Sale+OE | 83,372 | $31.96 | $2,664,215.76 | -9.8% | +6.6% | -41.9% | |
| Jun 17, 2021 | Spiegelman Daniel K59 | Director | Sell | 3,139 | $30.52 | $95,794.75 | -11.9% | +6.7% | -46.0% | |
| May 28, 2021 | Spiegelman Daniel K59 | Director | Sell | 7,142 | $28.99 | $207,023.01 | -34.7% | +17.1% | -19.3% |